N/A
Completed N=180
Testing the Effectiveness of WW Clinic GLP1
Source: ClinicalTrials.gov NCT06034457 ↗Enrolled (actual)
180
Serious AEs
0.0%
Results posted
Dec 2025
Primary outcomePrimary: Change in Weight in Pounds From Week 0 to Week 24 — -27.41 pounds
Summary
The study objective is to evaluate the efficacy of the WeightWatchers (WW) GLP-1 behavioral program + WW Clinic (formerly known as Sequence medical weight management program) on weight loss and related outcomes. Participants will be invited to take part and answer surveys at 0, 12 and 24 weeks.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Weight in Pounds From Week 0 to Week 24 |
-27.41 | — |
| SECONDARY Weight Loss Percentage Change From Week 0 to Week 24 |
161; 121; 81; 20 | — |
Eligibility Criteria
Inclusion criteria
- 18 years or older
- BMI of >30 or BMI of >27 with one or more weight related medically qualifying condition (hypertension, dyslipidemia, sleep apnea, cardiovascular disease)
- Access to a smartphone or tablet that runs iOS/iPadOS 15.0 or later, or Android 7.0 or later
- A prescription for Wegovy, Mounjaro, or Zepbound
Exclusion criteria
- Diabetes
- Personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2
- History of pancreatitis within 180 days
- Previous surgical obesity treatment
- Use of other anti-obesity medication in last 90 days
- Use of GLP-1 within the last 180 days
- Lost weight >11 lbs in the last 90 days
- Pregnant, breastfeeding, intends to become pregnant, of child-bearing potential and not using a highly effective contraceptive method
Data sourced from ClinicalTrials.gov (NCT06034457). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.